Related by context. All words. (Click for frequent words.) 71 standard chemotherapy regimens 71 immunosuppressive regimens 71 antiplatelet therapies 70 immunosuppressive agents 70 candidemia 70 GnRH agonists 70 MYCAMINE 70 immunosuppressive therapies 69 imatinib Gleevec 69 mycophenolate mofetil 69 lapatinib Tykerb 69 lenalidomide dexamethasone 69 calcineurin inhibitors 69 anti angiogenic agents 68 antiangiogenic agents 68 invasive candidiasis 68 OnDose TM 68 antiangiogenic therapy 68 relapsed MM 68 allogeneic HSCT 68 DMARDS 68 pegfilgrastim 68 thrombolytic agents 68 pegylated interferon alfa 68 lipid lowering therapies 68 somatostatin analogues 68 oral anticoagulation 68 trastuzumab Herceptin ® 68 anticancer therapies 68 riociguat 67 EGFR antibodies 67 lipid lowering agents 67 rituximab Rituxan 67 efalizumab 67 cediranib 67 chemotherapeutic regimens 67 dosage regimens 67 ofpatients 67 LHRH antagonists 67 monoclonal antibody therapies 67 APTIVUS r 67 antibiotic regimens 67 antiemetics 67 treatment regimens 67 tigecycline 67 paricalcitol 67 caspofungin 67 HAART regimen 67 thalidomide Thalomid 67 intravenous bisphosphonates 67 EGFR tyrosine kinase inhibitors 67 CTAP# Capsules 67 KRAS status 67 HAART regimens 67 docetaxel Taxotere ® 67 busulfan 67 interferon ribavirin 67 VAPRISOL 66 antithrombotics 66 TroVax ® 66 chemotherapies 66 cytotoxic chemotherapy 66 mapatumumab 66 plasminogen activators 66 antiplatelet medications 66 PROCHYMAL 66 K ras mutations 66 clevidipine 66 imatinib resistance 66 molecular biomarkers 66 antimicrobial prophylaxis 66 topical retinoids 66 APTIVUS 66 neovascular diseases 66 convenient dosing regimen 66 oral anticoagulant therapy 66 immunosuppressive medications 66 steroid dexamethasone 66 galiximab 66 aldosterone antagonist 66 endocrine therapies 66 protease inhibitor PI 66 direct thrombin inhibitors 66 immunosuppressives 66 antiplatelet drugs 66 MMP inhibitors 66 cytotoxic agents 66 dopaminergic therapy 66 TNF alpha antagonist 66 AGILECT R 66 uric acid lowering 66 immunomodulators 66 Perforomist ™ Inhalation Solution 66 docetaxel chemotherapy 66 erlotinib Tarceva ® 66 Dacogen decitabine 66 skeletal metastases 66 dasatinib Sprycel 66 Velcade bortezomib 66 pyridostigmine 66 adverse cytogenetics 66 Tekamlo 66 concomitant medications 66 infliximab Remicade 66 rituximab Rituxan ® 66 Candida infection 65 gemifloxacin 65 pharmacological therapies 65 azacitidine 65 nucleoside analogs 65 adjuvant therapies 65 velafermin 65 protease inhibitors PIs 65 pharmacodynamic parameters 65 levodopa carbidopa 65 Noxafil 65 anticonvulsant medications 65 cytotoxics 65 vidofludimus 65 SERMs 65 BeneFIX 65 aromatase inhibitor therapy 65 therapies 65 hormonal therapies 65 MAGE A3 ASCI 65 Bacillus Calmette Guerin BCG 65 pegylated liposomal doxorubicin 65 CANCIDAS 65 tamoxifen Nolvadex ® 65 recurrent GBM 65 FOLFIRINOX 65 concurrent chemoradiation 65 EGFR inhibitors 65 empiric therapy 65 AGHD 65 CBLC# 65 β blockers 65 genotypic resistance 65 molecularly targeted therapies 65 LEUKINE 65 cytoreduction 65 Gleevec resistant 65 idraparinux 65 stem cell transplantations 65 faropenem 65 intra arterial chemotherapy 65 radezolid 65 posaconazole 65 Doxil ® 65 decitabine 65 pharmacological approaches 65 QVAR 65 mitochondrial toxicity 65 fulvestrant 65 idarubicin 65 intranasal corticosteroids 65 monotherapies 65 convenient dosing regimens 65 imipenem 65 Cloretazine 65 relapsed ovarian cancer 65 anti angiogenic drugs 65 Mitoxantrone 65 sorafenib Nexavar 65 chemotherapy regimens 65 hepatic metastases 65 pyrazinamide 65 pharmacokinetic interactions 65 mTOR inhibitors 65 investigational therapies 65 OHR/AVR# 65 pharmacotherapies 65 antioxidant supplementation 65 intravesical therapy 65 INTERCEPT platelets 65 multitargeted 65 LHRH agonists 65 CellCept mycophenolate mofetil 65 dosing regimens 65 postoperative chemotherapy 64 forodesine 64 sipuleucel T 64 amphotericin B 64 intravenous cyclophosphamide 64 Topical corticosteroids 64 canakinumab 64 predictive biomarkers 64 gallium nitrate 64 standard chemotherapy regimen 64 Fludara 64 pramlintide metreleptin combination 64 platelet inhibitor 64 Fludara ® 64 calcineurin inhibitor 64 EGFR TKIs 64 treprostinil 64 preclinically 64 mealtime insulin 64 LNP formulations 64 Virulizin ® 64 Pseudomonas aeruginosa infections 64 infusional 64 antihypertensive agents 64 CYT# potent vascular disrupting 64 probiotic supplementation 64 oral rivaroxaban 64 pharmacologic intervention 64 TKI therapy 64 dosage regimen 64 immunodeficiency disorders 64 dexamethasone Decadron 64 anticancer treatments 64 corticosteroid therapy 64 salmeterol fluticasone 64 constipation OIC 64 Bcr Abl mutations 64 visilizumab 64 APTIVUS R 64 Nexavar sorafenib 64 MYLOTARG 64 aromatase inhibitors AIs 64 Xanafide 64 inhaled glucocorticoids 64 quinolone 64 micafungin 64 immunosuppressive regimen 64 Oral corticosteroids 64 iron chelators 64 BEXXAR Therapeutic Regimen 64 gemcitabine Gemzar 64 antiviral therapies 64 AZILECT ® 64 antiviral therapy 64 refractory angina 64 HCV protease inhibitors 64 anticancer therapy 64 rFVIIa 64 IV bisphosphonates 64 Dasatinib 64 radiochemotherapy 64 Symadex 64 Neulasta ® 64 CINTREDEKIN BESUDOTOX 64 NNRTIs 64 inhibitor RG# 64 liposomal amphotericin B 64 aspirin clopidogrel 64 stavudine d4T 64 trastuzumab Herceptin 64 antimetabolite 64 Bcr Abl inhibitors 64 phosphate binders 64 ClearPath HDR 64 antitumor efficacy 64 thromboprophylaxis 64 HGS# 64 pegylated interferons 64 dosing frequency 64 VEGF inhibitors 64 paclitaxel Taxol 64 Pemetrexed 64 antiepileptic drugs AEDs 64 renoprotective 64 levosimendan 64 NovaBay Aganocide compounds 64 EGFRIs 64 pharmacologic treatments 64 dosing schedules 64 thoracoscopic lobectomy 64 topical formulations 64 Anticalins ® 64 indinavir 64 docetaxel Taxotere 64 Hematologic 64 aldosterone antagonists 64 Th2 cytokines 64 pegylated IFN 64 JAK inhibitors 64 TNF inhibitor 64 folinic acid 64 Aggrastat ® tirofiban hydrochloride 64 CMV disease 64 boosted protease inhibitor 64 OMNARIS HFA 64 bortezomib Velcade 64 S/GSK# 64 Combination therapy 64 antiretroviral regimens 64 chemotherapeutics 64 MyVax R 64 nosocomial pneumonia 64 Gleevec imatinib 64 eTag assays 64 tipranavir 64 refractory CLL 64 HER2 overexpression 64 MGd 64 anticlotting drugs 64 unresectable tumors 64 oral anticoagulants 64 Lung transplantation 64 myopathy rhabdomyolysis 64 Vectibix monotherapy 64 antithrombotic therapy 64 HBV vaccine 64 demonstrated antitumor activity 64 chemotherapeutic agents 64 nomograms 64 immunomodulatory therapy 64 colorectal liver metastases 63 topical NSAIDs 63 bevacizumab Avastin ® 63 androgen ablation 63 bexarotene 63 Revlimid lenalidomide 63 erlotinib Tarceva 63 MEK inhibitors 63 PREZISTA r 63 HIV HCV coinfected 63 Nilotinib 63 anticoagulant warfarin 63 alpha interferons 63 sorafenib tablets 63 Surgical resection 63 bendamustine 63 DermaVir 63 paclitaxel Taxol ® 63 cytotoxic therapy 63 irinotecan chemotherapy 63 macrolide antibiotic 63 ritonavir boosted protease inhibitor 63 Adjuvant chemotherapy 63 cytoreductive surgery 63 immunomodulation 63 imatinib therapy 63 pharmacological intervention 63 combination antiretroviral therapy 63 AST ALT 63 CYP#A# inhibitors 63 anti tubercular 63 nonpharmacologic 63 inhaled bronchodilators 63 fluoropyrimidine 63 immunotoxins 63 chemopreventive agents 63 Neuradiab 63 HuLuc# 63 immune modulating 63 corticosteroid dexamethasone 63 NCCN guidelines 63 antiangiogenic drugs 63 warfarin therapy 63 Natalizumab 63 SCIg 63 viral kinetics 63 cMET 63 Hizentra 63 intraperitoneal chemotherapy 63 recurrent glioblastoma multiforme 63 EXJADE 63 oral NSAIDs 63 pertuzumab 63 INTELENCE 63 ACTEMRA TM 63 cefepime 63 beta interferons 63 metastatic neuroendocrine tumors 63 imexon 63 TPI ASM8 63 antisense compounds 63 recurrent glioblastoma 63 therapeutic modalities 63 TMP SMX 63 antihypertensive therapy 63 autologous hematopoietic stem cell 63 THALOMID 63 acyclovir Lauriad R 63 potent antiretroviral therapy 63 vasodilators 63 Atypical antipsychotics 63 ziconotide 63 MyVax ® 63 Torisel 63 treating neuropathic pain 63 dose cytarabine 63 budesonide foam 63 vorinostat 63 gemcitabine carboplatin 63 cranial irradiation 63 glycosylated hemoglobin levels 63 antiretroviral regimen 63 abiraterone acetate 63 ritonavir boosted 63 transplantation HCT 63 interventional therapies 63 Targretin 63 immunomodulatory therapies 63 gefitinib Iressa 63 Pegasys peginterferon alfa 2a 63 hemorrhagic complications 63 Privigen 63 p# biomarker 63 KL4 surfactant 63 motesanib 63 ocular disorders 63 metastatic RCC 63 angiographic outcomes 63 induce remission 63 Zemplar Capsules 63 Allovectin 7 ® 63 EFAPROXYN 63 lupus nephritis 63 IgG1 antibodies 63 eculizumab therapy 63 Aloxi injection 63 antiplatelet medication 63 Pegylated Interferon 63 H. pylori eradication 63 PDE4 inhibitors 63 hydroxychloroquine 63 Candesartan 63 interferon alfa 63 flecainide 63 OMP #M# 63 surgical debulking 63 noscapine 63 pimecrolimus 63 KAPIDEX 63 baseline LDH 63 thromboembolic disease 63 cinacalcet 63 overlapping toxicities 63 epithelial tumors 63 inecalcitol 63 BYETTA exenatide injection 63 antidiabetic drugs 63 Vidaza azacitidine 63 surrogate endpoint 63 ONTAK 63 HepaMate 63 AZT zidovudine Retrovir 63 virologic responses 63 meropenem 63 amoxicillin clavulanate 63 Thalomid ® 63 GnRH antagonists 63 trospium 63 RLY# 63 bicalutamide 63 cancer immunotherapies 63 hA# 63 Altastaph 63 alefacept 63 intravenous immunoglobulin IVIg 63 Vidaza ® 63 low dose cytarabine 63 androgen deprivation 63 Eraxis 63 lenalidomide Revlimid R 63 INCB# [001] 63 ribavirin RBV 63 YONDELIS 63 Pertuzumab 63 Interferon alpha 63 NMDA antagonists 63 external beam radiotherapy 63 dyslipidemias 63 DAPT 63 endometrial hyperplasia 63 mycophenolate mofetil MMF 63 fibrate drugs 63 ruxolitinib 63 receptor tyrosine kinase inhibitor 63 solid organ transplantation 63 voriconazole 63 d4T stavudine Zerit 63 gp# vaccine 63 ENMD # 63 thrombolytics 63 iniparib 63 injectable formulations 63 nucleoside analogues 63 inhaled corticosteroid therapy 63 cIAI 63 CIMZIA ™ 63 basal bolus regimen 63 SPRYCEL ® 63 antibiotic prophylaxis 63 aerosolized KL4 surfactant 63 Gefitinib 63 abacavir Ziagen 63 Gleevec imatinib mesylate 63 adalimumab Humira 63 BCR ABL mutations 62 interferon alfa 2b 62 anti coagulant therapy 62 PEGPH# 62 ALK inhibitors 62 pentoxifylline 62 Non inferiority 62 antithrombotic agents 62 HBeAg negative 62 NAbs 62 RAS mutations 62 carboplatin paclitaxel 62 isoproterenol 62 oncologic outcomes 62 Severe Primary IGFD 62 delafloxacin 62 pharmacological interventions 62 NATRECOR ® 62 mTOR inhibition 62 ZYTIGA 62 sargramostim 62 ganciclovir 62 PXD# 62 interferon therapy 62 oral prodrug 62 pamidronate 62 neuroendocrine cancers 62 chemoprevention trials 62 Starlix 62 Cimzia TM 62 thrombotic complications 62 liposomal formulations 62 antithymocyte globulin 62 Zometa zoledronic acid 62 immunological responses 62 ritonavir boosted lopinavir 62 noninfectious uveitis 62 systemic immunosuppressive drugs 62 renal tumors 62 PROLASTIN 62 ALI ARDS 62 Rifampin 62 PYY nasal spray 62 hematological parameters 62 atovaquone 62 mesalamine granules 62 ROTARIX 62 refractory gout 62 TELINTRA 62 hematological malignancy 62 atypical hemolytic uremic syndrome 62 cilengitide 62 prognostic markers 62 investigational monoclonal antibody 62 Triapine R 62 GnRH antagonist 62 Inhaled corticosteroids 62 dose proportional pharmacokinetics 62 cidofovir 62 overactive bladder syndrome 62 agomelatine 62 prognostic variables 62 relapsed multiple myeloma 62 gastrointestinal stromal tumors GIST 62 FUSILEV enhances 62 cisplatin chemotherapy 62 antihypertensive drugs 62 doxercalciferol 62 daptomycin 62 pancreatic adenocarcinoma 62 Thal Dex 62 systemic corticosteroids 62 favorable pharmacokinetic profile 62 SUPPRELIN R LA 62 benign prostatic hypertrophy BPH 62 enzastaurin 62 Telintra 62 INCB# [003] 62 fluoroquinolone resistance 62 pomalidomide 62 methotrexate therapy 62 tolerability profiles 62 xenograft models 62 perioperative morbidity 62 Paromomycin 62 Liprotamase 62 TNF alpha inhibitor 62 Vaprisol 62 antitumor effect 62 goserelin 62 kidney urologic 62 etanercept Enbrel 62 tanespimycin 62 long acting bronchodilator 62 poliovirus vaccine 62 teriflunomide 62 CHOP chemotherapy 62 Lenocta 62 antiplatelet agents 62 TRV# [001] 62 hematopoietic malignancies 62 SERCA2a 62 liposomal doxorubicin 62 haematological malignancies 62 certolizumab 62 bovine thrombin 62 Platinol ® 62 Rapaflo 62 HIPEC 62 tuberculin skin testing 62 adipiplon 62 personalized immunotherapy 62 antiplatelets 62 neratinib 62 haematopoietic 62 superficial bladder cancer 62 sodium stibogluconate 62 differentiated thyroid 62 myeloablative 62 Azedra 62 Degarelix 62 Renal Cell Carcinoma RCC 62 systemic fungal infections 62 Panzem R NCD 62 antiepileptics 62 deferiprone 62 PhG alpha 1 62 TTF Therapy 62 chronic GVHD 62 VDAs 62 taxane therapy 62 piperacillin tazobactam 62 analgesic medications 62 Warfarin Coumadin 62 nucleoside analog 62 glatiramer 62 GI motility disorders 62 intravenous diuretics 62 relapsed ALL 62 oxybutynin gel 62 molecularly targeted 62 ORENCIA R 62 cannabinor 62 topotecan 62 invasive aspergillosis 62 Exforge HCT 62 IFN beta 62 octreotide LAR 62 endothelin receptor antagonists 62 dacetuzumab 62 Mepact 62 myelomas 62 acromegalic patients 62 CsA 62 Zevalin consolidation 62 macrolide antibiotics 62 resynchronization therapy 62 Afatinib 62 hepatorenal syndrome 62 griseofulvin 62 Mitomycin C 62 dose regimens 62 IGIV 62 dacarbazine 62 myoblast therapy 62 systemic corticosteroid 62 Gliadel Wafer 62 PROLARIS 62 RISPERDAL ® 62 MP4OX 62 YERVOY 62 refractory AML 62 hematologic parameters 62 statin medications 62 VFEND 62 alvespimycin 62 novel peptide 62 Proquin XR 62 intravenous iv 62 immune reconstitution 62 paclitaxel Taxol R 62 lumiliximab 62 Alocrest 62 paclitaxel eluting stents 62 Alequel 62 percutaneous drainage 62 pyrimethamine 62 maximally tolerated 62 Cerashield 62 transplantation HSCT 62 subcutaneous immunoglobulin 62 Campath alemtuzumab 62 dexrazoxane 62 chemotherapeutic regimen 62 GAP #B# 62 LVRS 62 mRCC 62 autologous platelet gel 62 trans retinoic acid 62 antiinflammatory drugs 62 lanreotide 62 pharmacological treatments 62 ISTODAX 62 allogeneic hematopoietic stem cell 62 biotherapies 62 Teriflunomide 62 radioiodine therapy 62 multimodality therapy 62 rhIGF-I/rhIGFBP-3 62 Corticosteroids 62 antiandrogens 62 serum calcium levels 62 HIV protease inhibitors 62 coronary stenting 62 Elitek 62 antithrombotic 62 epigenetic therapies 62 liver metastasis 62 PegIFN RBV 62 invasive fungal infections 62 OncoVEX GM CSF 62 Desferal 62 iclaprim 62 INTEGRILIN 62 ponatinib 62 primary hyperparathyroidism 62 Navelbine ® 62 lipid lowering medication 62 antiarrhythmic drug 62 Combo Stent 62 Platinol ® cisplatin 62 topical calcineurin inhibitors 62 Topical treatments 62 cytotoxic therapies 62 streptokinase 62 BEXXAR 62 TNF alpha inhibitors 62 Aspergillus infections 62 metastatic malignant melanoma 62 therapies ACTs 62 Cardiotoxicity 62 KETEK 62 Isentress raltegravir 62 antiarrhythmic drugs 62 amisulpride 62 relapsed SCLC 62 adjuvant therapy 62 dapsone 62 fluvastatin 62 ara C 62 OncoVEX 62 oxaliplatin Eloxatin 62 palliative radiotherapy 62 cART 62 antirheumatic 62 GVAX Pancreas Vaccine 62 humanised monoclonal antibody 62 TREDAPTIVE 62 suppressive therapy 62 Factor Xa inhibitors 62 ALA PDT 62 ATACAND 62 zidovudine AZT 62 biomarker identification 62 itraconazole 62 Octreolin 62 skeletal myoblasts 62 nicardipine 62 HSCT 62 Zolinza 62 Corus CAD 62 tenofovir emtricitabine 62 ChronVac C R 62 symptomatic paroxysmal AF 62 elotuzumab 61 Meta analyzes 61 PSMA ADC 61 Alessandro Riva 61 microtubule inhibitor 61 intensive lipid lowering 61 ganaxolone 61 microwave hyperthermia 61 ELACYT 61 Cytolin R 61 alfuzosin 61 antiplatelet therapy 61 Xelox 61 temsirolimus 61 Neupogen ® 61 Insulin detemir 61 Src inhibitors 61 hypereosinophilic syndrome 61 biologic DMARD 61 efaproxiral 61 nucleotide analogue 61 ACZ# 61 ZYVOX 61 lomitapide 61 CA4P 61 GIST tumors 61 dacarbazine chemotherapy 61 secondary amenorrhea 61 antimetabolites 61 panobinostat 61 ACE inhibitor lisinopril 61 antihypertensive therapies 61 DOXIL 61 Vandetanib 61 anidulafungin 61 oblimersen 61 Revimmune 61 Effexor venlafaxine 61 Vidofludimus 61 Cleviprex TM clevidipine 61 BEXXAR therapeutic regimen 61 XmAb# 61 Smac mimetics 61 chemoradiotherapy 61 buprenorphine naloxone 61 uridine triacetate 61 rt PA 61 ß blockers 61 NNRTI resistant virus 61 alkylating agent 61 NEUMUNE 61 leukotriene receptor antagonist 61 metastatic lung cancer 61 tyrosine kinase inhibitor TKI 61 antifungal medications 61 dirucotide MBP# 61 lymphoma subtypes 61 Hydroxyurea 61 T#I [002] 61 Hepatocellular Carcinoma HCC 61 oral deforolimus 61 potentially hepatotoxic 61 myelofibrosis polycythemia vera 61 pulmonary exacerbations 61 Zavesca R 61 xanthine oxidase inhibitor 61 valganciclovir 61 DFMO 61 p# activation 61 serum phosphorous 61 colorectal cancer liver metastases 61 Riluzole 61 Deforolimus 61 MGN# 61 ZOLINZA 61 OnDose 61 PASI scores 61 TOCOSOL Camptothecin 61 DACH platinum 61 histological subtypes 61 postoperative pulmonary 61 cystinosis patients 61 GAMMAGARD 61 anti angiogenic therapy 61 terlipressin 61 Tavocept 61 allogeneic SCT 61 tumor subtypes 61 regorafenib 61 Immunotherapeutic 61 indolent NHL 61 PPAR gamma agonists 61 interferon beta therapy 61 biologic DMARDs 61 Femara letrozole 61 chlorthalidone 61 divalproex sodium 61 relapsing MS 61 Targretin capsules 61 somatostatin analogs 61 revascularization procedures 61 fusion enhancers 61 non selective NSAIDs 61 conventional DMARDs 61 PNH patients 61 pharmacodynamic markers 61 dexanabinol 61 TNF blocker therapy 61 trastuzumab Herceptin R 61 doxorubicin docetaxel 61 palifermin 61 Myocet 61 peritoneal carcinomatosis 61 KRAS mutation 61 efavirenz Sustiva 61 zoledronate 61 serum phosphate levels 61 liver histology 61 CD# antibody [001] 61 pharmacologic approaches 61 dasatinib 61 Cyclosporine 61 pancreatic insufficiency 61 bevacizumab Avastin 61 SPIRIVA HandiHaler 61 Darinaparsin 61 lung resection 61 pharmacodynamic endpoints 61 mAbs 61 follicular lymphoma FL 61 nalbuphine ER 61 Pazopanib 61 Personalized Immunotherapy 61 VTE prophylaxis 61 cSSSIs 61 hematologic toxicity 61 LATUDA 61 acid suppressive medications 61 BCR ABL inhibitor 61 Chemophase 61 NEUPOGEN 61 allergen immunotherapy 61 LHRH analogues 61 Taxotere chemotherapy 61 Islet transplantation 61 reslizumab 61 Dose adjustments 61 BrachySil TM 61 tacrolimus ointment 61 evaluating tivozanib 61 SIR Spheres 61 lipid abnormalities 61 intravenous immunoglobulin 61 bezafibrate 61 fluticasone salmeterol 61 Gilead Viread 61 fosamprenavir 61 NOXAFIL 61 FXIII 61 Foradil Aerolizer 61 Tacrolimus 61 clomipramine 61 PROLASTIN C 61 chemoembolization 61 Carvedilol 61 tumor necrosis 61 intracranial hemorrhage ICH 61 HCV infections 61 DMARD therapy 61 oral antidiabetes drugs 61 ursodeoxycholic acid 61 biotherapy 61 TYZEKA 61 antiepileptic medications 61 taxane resistant 61 dalteparin 61 neoplastic diseases 61 curative therapy 61 peginterferon 61 pharmacokinetic equivalence 61 STELARA ™ 61 TYGACIL 61 chlamydial 61 vicriviroc 61 carbohydrate polymers 61 insulin analogs 61 betamethasone dipropionate 61 virological suppression 61 vivo potency 61 mupirocin 61 hereditary deficiency 61 sunitinib malate 61 cangrelor 61 nadolol 61 vinorelbine 61 leukemia AML 61 TNFa 61 ARIKACE ™ 61 GRASPA ® 61 tolterodine ER 61 weekly subcutaneous injections 61 calcitonin 61 renal toxicity 61 antidiabetic therapy 61 renal allograft 61 5-FU/LV 61 pharmacogenetic testing 61 5 FU 61 NAVISTAR R 61 selective modulator 61 ribavirin therapy 61 IOP lowering 61 null responder 61 nonsurgical treatments 61 ICD therapy 61 primidone 61 pimozide 61 Dalbavancin 61 Cellcept 61 Cytarabine 61 NPH insulin 61 INVEGA ® 61 androgen suppression therapy 61 TBC# 61 metastatic sarcoma 61 lenalidomide Revlimid 61 paclitaxel cisplatin 61 diabetic neuropathic pain 61 cephalosporin antibiotics 61 DCVax ® Brain 61 antiandrogen 61 neuro psychiatric disorders